CompletedNot Applicable

KP-Led Same Day HCV Test and Treat Study

Thailand200 participantsStarted 2023-08-17

Plain-language summary

This is a Hybrid design to primarily assess effectiveness, and to secondarily observe and collect data on the implementation of the service. This will allow the assessment of health-related outcomes and implementation outcomes to facilitate dissemination and replication if proven to be successful in other CBOs in Thailand, regionally, and globally.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Eligibility criteria for assessment of effectiveness outcomes: Inclusion Criteria: * Thai citizen * 18 years or older * Signed informed consent * Tested anti-HCV positive Exclusion Criteria: * Decline to participate in the research Eligibility criteria assessment of implementation outcomes: Inclusion criteria: * Client level: Tested anti-HCV positive at one of the implementing CBOs * Provider level: KP lay providers providing KP-led Same Day HCV Test and Treat * Leadership level: leadership of implementing CBOs * Government level: involved in policy making related to HCV testing and treatment in key populations Exclusion criteria: * Do not provide informed consent to participate in the research

What they're measuring

The proportion of eligible clients initiating DAAs

Timeframe: 18 months

The proportion of complete tretmented client

Timeframe: 18 months

The proportion of SVR achieved client

Timeframe: 18 months

Trial details

NCT IDNCT05479760

SponsorInstitute of HIV Research and Innovation Foundation, Thailand

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-15

View on ClinicalTrials.gov More HCV, HIV trials